Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

16 Feb 2018 at 00:00

OJEU - F3 - Contract Award Notice
Tender

01 Sep 2017 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The procurement process is led by The Common Services Agency, also known as NHS National Services Scotland, for the framework agreement titled "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine." This procurement falls within the health industry category and is located in Edinburgh, UK. The process is currently at the Award stage, following the open procurement method, with the tender period having ended on 3rd October 2017. An estimated contract value is £30,788,325, covering various lots intended for supply to Health Boards across NHS Scotland.

This tender presents substantial opportunities for businesses involved in the pharmaceutical sector, particularly those specialising in analgesics and anaesthetic products. Companies that manufacture or supply generic medicines, particularly those compliant with the relevant UK and European regulations, will be well-suited to compete for the contracts. Given the segmented lots, there is potential for multiple suppliers to be awarded, thereby increasing the scope for small to medium-sized enterprises, as well as larger pharmaceutical companies, to engage in this lucrative framework agreement.

How relevant is this notice?

Notice Information

Notice Title

Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine

Notice Description

This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice

Lot Information

Lot 2 Oxycodone Injections

The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 1 Baclofen Intrathecal Injections

Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets

The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 5 Buprenorphine Patches

The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Lot 6 Fentanyl Tablets (Sublingual)

The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Lot 7 Fentanyl Sf Tablet (Buccal)

Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 8 - Fentanyl Transdermal Patch

Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 9 - Hydromorphone Capsule

Supply of Hydromorphone Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product lines as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Lot 10 - Lidocaine Chlorhexidine Gel

Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)

Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)

The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 13 - Morphine Sulfate Modified-Release Tablet

The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 14 - Oxycodone Hydrochloride Capsule

The Supply of Oxycodone Hydrochloride Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 15 - Propofol Injection

The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 16 - Tramadol Hydrochloride Modified Release Tablet

The Supply of Tramadol Hydrochloride Modified Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 17 - Oxycodone Oral Solution

The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines

Supply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority intends awarding each line within this Lot to a single supplier.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection

The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000510037
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£30,788,325 £10M-£100M
Lots Value
£30,788,319 £10M-£100M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Feb 20188 years ago
Submission Deadline
3 Oct 2017Expired
Future Notice Date
Not specified
Award Date
22 Dec 20178 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...